Published in Clin Exp Immunol on March 01, 2014
Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS. Neurology (2015) 2.07
Neuroinflammation of the central and peripheral nervous system: an update. Clin Exp Immunol (2014) 0.76
IFN beta 1a as Glucocorticoids-Sparing Therapy in a Patient with CLIPPERS. Am J Case Rep (2016) 0.75
Horizontal eyeball akinesia as an initial manifestation of CLIPPERS: Case report and review of literature. Medicine (Baltimore) (2016) 0.75
Relapsing-Remitting Severe Bickerstaff's Brainstem Encephalitis - Case Report and Literature Review. Pol J Radiol (2016) 0.75
Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS) with Limbic Encephalitis. Intern Med (2017) 0.75
CLIPPERS. Curr Neurol Neurosci Rep (2017) 0.75
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain (2010) 4.77
Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. Lancet Neurol (2009) 3.69
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol (2010) 3.28
Expanding the clinical, radiological and neuropathological phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). J Neurol Neurosurg Psychiatry (2011) 2.65
Fatal B-cell lymphoma following chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. JAMA Neurol (2013) 2.47
Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients. Arch Neurol (2012) 2.13
Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol (2008) 1.57
Three cases of CLIPPERS: a serial clinical, laboratory and MRI follow-up study. J Neurol (2011) 1.43
3.0T MR investigation of CLIPPERS: role of susceptibility weighted and perfusion weighted imaging. Magn Reson Imaging (2013) 1.42
Serial stereotactic biopsy of brainstem lesions in adults improves diagnostic accuracy compared with MRI only. J Neurol Neurosurg Psychiatry (2009) 1.26
Contrast-enhanced magnetic resonance imaging and perfusion-weighted imaging for monitoring features in severe CLIPPERS. Brain (2011) 1.08
Brain biopsy is required in steroid-resistant patients with chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). J Neurooncol (2011) 1.06
The expanding phenotype of CLIPPERS: is it a disease or a syndrome? J Neurol Neurosurg Psychiatry (2012) 1.06
Rhombencephalitis / brainstem encephalitis. Curr Neurol Neurosci Rep (2011) 1.02
Myelitis with atopic diathesis: a nationwide survey of 79 cases in Japan. J Neurol Sci (2003) 1.01
Requirement for safety monitoring for approved multiple sclerosis therapies: an overview. Clin Exp Immunol (2014) 1.00
A new case of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids with initial normal magnetic resonance imaging. Brain (2011) 0.98
CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Pract Neurol (2011) 0.97
Atypical chronic lymphocytic inflammation with pontocerebellar perivascular enhancement responsive to steroids (CLIPPERS), primary angiitis of the CNS mimicking CLIPPERS or overlap syndrome? A case report. J Neurol Sci (2012) 0.95
'Radiologically compatible CLIPPERS' may conceal a number of pathologies. Brain (2011) 0.95
Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies. Clin Exp Immunol (2014) 0.95
An elderly patient with Bickerstaff brainstem encephalitis and transient episodes of brainstem dysfunction. Arch Neurol (2008) 0.94
Response to immunotherapy in CLIPPERS: clinical, MRI, and MRS follow-up. J Neuroimaging (2011) 0.94
CLIPPERS-like MRI findings in a patient with multiple sclerosis. J Neurol Sci (2013) 0.93
Monoclonal antibodies in treatment of multiple sclerosis. Clin Exp Immunol (2014) 0.91
A new case of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Brain (2011) 0.90
Vasogenic edema in Bickerstaff's brainstem encephalitis: a serial MRI study. Neurology (2003) 0.88
Need for prolonged immunosupressive therapy in CLIPPERS--a case report. BMC Neurol (2013) 0.87
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids following influenza vaccination. Arch Pathol Lab Med (2012) 0.86
Response to immunotherapy in CLIPPERS syndrome. J Neurol (2011) 0.85
A case of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) in East Asia. Intern Med (2012) 0.85
Brain biopsy in cryptogenic neurological disease. Br J Neurosurg (2011) 0.85
Myelitis associated with atopic disorders in Japan: a retrospective clinical study of the past 20 years. Intern Med (2001) 0.82
Cutting-edge questions about CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids). Arch Neurol (2012) 0.82
CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma. Neurology (2012) 0.81
Teaching neuroimages: punctuate and curvilinear enhancement peppering the pons responsive to steroids. Neurology (2011) 0.79
The other BSE. Brain (2011) 0.78
[Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids]. Nervenarzt (2012) 0.78
Paraneoplastic brain stem encephalitis. Curr Treat Options Neurol (2013) 0.77
[CLIPPERS: an increasingly diagnosed syndrome]. Nervenarzt (2012) 0.76
Induction of plasticity in the human motor cortex by paired associative stimulation. Brain (2000) 4.52
Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol (1999) 2.52
Disturbance of sequential movements in patients with Parkinson's disease. Brain (1987) 2.30
Performance of simultaneous movements in patients with Parkinson's disease. Brain (1986) 1.95
Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology (2003) 1.89
What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group. J Neurol Neurosurg Psychiatry (1998) 1.69
On the origin of the postexcitatory inhibition seen after transcranial magnetic brain stimulation in awake human subjects. Exp Brain Res (1993) 1.51
Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci (2011) 1.49
Monitoring the effectiveness of anticoagulative therapy in left atrial spontaneous echo contrast by cerebral microemboli detection. Stroke (1999) 1.47
Transcranial brain sonography findings predict disease progression in multiple sclerosis. Neurology (2009) 1.46
Sporadic focal dystonia in northwest Germany: molecular basis on chromosome 18p. Ann Neurol (1997) 1.43
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology (2008) 1.39
Thalamic metbolism and corticospinal tract integrity determine motor recovery in stroke. Ann Neurol (1996) 1.34
Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies. Acta Neuropathol (2000) 1.33
The motor syndrome associated with exaggerated inhibition within the primary motor cortex of patients with hemiparetic. Brain (1997) 1.29
Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group. J Neurol (1999) 1.26
The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement. Brain (1988) 1.23
Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a German family with adult onset, autosomal dominant inheritance and purely focal distribution. Hum Mol Genet (1996) 1.22
Diagnosis and management of acute movement disorders. J Neurol (2005) 1.16
Cutaneomotor integration in humans is somatotopically organized at various levels of the nervous system and is task dependent. Exp Brain Res (2000) 1.12
Magnetic stimuli applied over motor and visual cortex: influence of coil position and field polarity on motor responses, phosphenes, and eye movements. Electroencephalogr Clin Neurophysiol Suppl (1991) 1.11
Simple and complex movements in a patient with infarction of the right supplementary motor area. Mov Disord (1986) 1.10
Motor strategies involved in the performance of sequential movements. Exp Brain Res (1986) 1.10
The Bereitschaftspotential is abnormal in Parkinson's disease. Brain (1989) 1.09
Simple and complex movements off and on treatment in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1987) 1.09
Frequency of familial inheritance among 488 index patients with idiopathic focal dystonia and clinical variability in a large family. Mov Disord (1997) 1.08
Associated postural adjustments in Parkinson's disease. J Neurol Neurosurg Psychiatry (1986) 1.06
Probable multiple system atrophy in a German family. J Neurol Neurosurg Psychiatry (2004) 1.05
Botulinum toxin: from poison to remedy. Neurotoxicology (1997) 1.03
The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J Neuroimmunol (2001) 1.03
Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry. J Neurol Sci (2012) 1.02
[Botulinum toxin in therapy of craniocervical dystonia]. Nervenarzt (1989) 1.01
Transcallosally mediated inhibition of interneurons within human primary motor cortex. Exp Brain Res (1996) 1.01
Requirement for safety monitoring for approved multiple sclerosis therapies: an overview. Clin Exp Immunol (2014) 1.00
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis. Brain (2009) 0.99
Evaluation of intracranial pressure from transcranial Doppler studies in cerebral disease. J Neurol (1988) 0.99
Deep brain stimulation of globus pallidus internus in a 16-year-old boy with severe tourette syndrome and mental retardation. Neuropediatrics (2010) 0.98
High penetrance and pronounced variation in expressivity of GCH1 mutations in five families with dopa-responsive dystonia. Ann Neurol (1998) 0.97
The EBD test--a clinical test for the detection of antibodies to botulinum toxin type A. Mov Disord (1997) 0.97
Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology (2005) 0.96
Effects of type A botulinum toxin on the cholinergic transmission at spinal Renshaw cells and on the inhibitory action at Ia inhibitory interneurones. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.95
Rifampin reduces production of reactive oxygen species of cerebrospinal fluid phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis. J Infect Dis (2000) 0.95
Persistent chorea after recurrent hypoglycemia. A case report. Eur Neurol (1993) 0.94
Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology (2004) 0.94
Denervation activity in the EMG of patients with upper motor neuron lesions: time course, local distribution and pathogenetic aspects. J Neurol (1983) 0.93
Multimodal output mapping of human central motor representation on different spatial scales. J Physiol (1998) 0.93
Dose standardization of botulinum toxin. Mov Disord (1998) 0.92
Effects of an antispastic drug (beta-(4-chlorophenyl)-gamma-aminobutyric acid) on Renshaw cell activity. Neuropharmacology (1974) 0.92
Transcallosal inhibition in amyotrophic lateral sclerosis. Clin Neurophysiol (2006) 0.92
Monoclonal antibodies in treatment of multiple sclerosis. Clin Exp Immunol (2014) 0.91
The silent period after transcranial magnetic stimulation is of exclusive cortical origin: evidence from isolated cortical ischemic lesions in man. Neurosci Lett (1994) 0.91
Tetanus toxin induced actions on spinal Renshaw cells and Ia-inhibitory interneurones during development of local tetanus in the cat. Exp Brain Res (1977) 0.90
Multiple sclerosis treatment and infectious issues: update 2013. Clin Exp Immunol (2014) 0.90
Central motor pathways in patients with mirror movements. J Neurol Neurosurg Psychiatry (1991) 0.90
Inhibitory actions of motor cortex following unilateral brain lesions as studied by magnetic brain stimulation. Exp Brain Res (1994) 0.90
An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport). BMJ Open (2013) 0.90
Insular stroke is associated with acute sympathetic hyperactivation and immunodepression. Eur J Neurol (2012) 0.90
Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm (Vienna) (2002) 0.89
[Deep brain stimulation for Parkinson's disease. Consensus recommendations of the German Deep Brain Stimulation Association]. Nervenarzt (2009) 0.89
T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy. Brain (2000) 0.88
H2O2 and nitric oxide-mediated oxidative stress induce apoptosis in rat skeletal muscle myoblasts. J Neuropathol Exp Neurol (1996) 0.88
The flexor reflex--influence of stimulus parameters on the reflex response. Electroencephalogr Clin Neurophysiol (1985) 0.88
The Bereitschaftspotential, L-DOPA and Parkinson's disease. Electroencephalogr Clin Neurophysiol (1987) 0.88
Palliative care in patients with severe multiple sclerosis: two case reports and a survey among German MS neurologists. Palliat Med (2007) 0.88
Escalating immunotherapy of multiple sclerosis--new aspects and practical application. J Neurol (2004) 0.88
Variability of cortically evoked motor responses in multiple sclerosis. Electroencephalogr Clin Neurophysiol (1991) 0.87
Evidence for DYT7 being a common cause of cervical dystonia (torticollis) in Central Europe. Am J Med Genet (1997) 0.87
The silent period induced by transcranial magnetic stimulation in muscles supplied by cranial nerves: normal data and changes in patients. J Neurol Neurosurg Psychiatry (1995) 0.86
Electromyographic analysis of bicycling on an ergometer for evaluation of spasticity of lower limbs in man. Adv Neurol (1983) 0.86
Cerebral network underlying unilateral motor neglect: evidence from positron emission tomography. J Neurol Sci (1994) 0.86
Spasticity in patients with multiple sclerosis--clinical characteristics, treatment and quality of life. Acta Neurol Scand (2013) 0.86
Demyelination and axonal degeneration in corpus callosum assessed by analysis of transcallosally mediated inhibition in multiple sclerosis. Clin Neurophysiol (1999) 0.86
Increase of the Bereitschaftspotential in simultaneous and sequential movements. Neurosci Lett (1985) 0.86
[Chronic neuropathy of the suprascapular nerve in high performance athletes]. Nervenarzt (1988) 0.86
Lipocortin-1 (annexin-1) suppresses activation of autoimmune T cell lines in the Lewis rat. J Neuroimmunol (1996) 0.86
Modulation of transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD) by medication with methylphenidate (MPH). Neurosci Lett (2006) 0.85
[MS registry in Germany--design and first results of the pilot phase]. Nervenarzt (2005) 0.85
Time course transcriptomics of IFNB1b drug therapy in multiple sclerosis. Autoimmunity (2010) 0.85
[Normal values and age-related changes in magneto-electric evoked compound muscle potentials]. EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb (1992) 0.85
Responses of Renshaw cells to muscle ramp stretch. Exp Brain Res (1974) 0.84
Carbon disulfide mediated protein cross-linking by N,N-diethyldithiocarbamate. Chem Res Toxicol (1995) 0.84
Motor responses evoked by magnetic brain stimulation in Huntington's disease. Electroencephalogr Clin Neurophysiol (1992) 0.84
[Experience with levetiracetam in the treatment of status epilepticus]. Fortschr Neurol Psychiatr (2012) 0.84
Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis. Ann Neurol (2001) 0.84
Task-dependent modulation of inhibitory actions within the primary motor cortex. Exp Brain Res (1999) 0.84
Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment. Pharmacogenomics J (2010) 0.84
Epileptic seizures triggered directly by focal transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol (1995) 0.83
Inhibitory phenomena in individual motor units induced by transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol (1995) 0.83
Intergenomic consensus in multifactorial inheritance loci: the case of multiple sclerosis. Genes Immun (2004) 0.83
[The role of magnetic stimulation in diagnosis of the peripheral nervous system]. EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb (1988) 0.83
Effects of repeated intrathecal triamcinolone-acetonide application on cerebrospinal fluid biomarkers of axonal damage and glial activity in multiple sclerosis patients. Mol Diagn Ther (2014) 0.82
Recurrent aphasic status epilepticus after prolonged generalized tonic-clonic seizures versus a special feature of Todd's paralysis. Epilepsy Behav (2010) 0.82
Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment. Pharmacogenomics J (2011) 0.82
[Successful corticoid treatment of lumbosacral plexus neuropathy in heroin abuse. Clinical aspects, electrophysiology, therapy and follow-up]. Nervenarzt (1988) 0.82